secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLOBUS MEDICAL INC (GMED)
CIK:        0001237831
Form:       8-K
Filed at:   2025-02-06T23:59:59+00:00
Accession:  0001193125-25-021848
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Globus Medical to acquire Nevro for $5.85/sh in all-cash deal valued at ~$250M
------------------------------------------------------------------------------

- All-cash transaction at $5.85/share; 27% premium to 90-day VWAP of $4.61.
- Total equity value approx. $250M; expected close by late Q2 2025.
- Globus Medical expects Nevro acquisition to be accretive to earnings in second year.
- Globus reaffirms standalone 2025 net sales guidance $2.66-$2.69B; combined guidance $2.80-$2.90B.
- Preliminary 2024 revenue: Globus $2.52B (+60.6% YoY); Nevro $408-$409M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1237831/000119312525021848/0001193125-25-021848-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1237831/000119312525021848/d849414d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-021848

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer